Cyclohexane

Cyclohexane

SCHEMBL2800628

C1CCCCC1.CCCC(=O)O.[Co]

nearest known ligand 0.77

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FFAR3 O14843 2/20 0.77
HDAC3 O15379 1/20 0.77
HDAC1 Q13547 1/20 0.77
HDAC2 Q92769 1/20 0.77
HDAC8 Q9BY41 1/20 0.77
AKR1B1 P15121 1/20 0.50
GPR84 Q9NQS5 7/20 0.48
PPARG P37231 7/20 0.48
PPARD Q03181 7/20 0.48
PPARA Q07869 7/20 0.48
HDAC11 Q96DB2 5/20 0.48
TSHR P16473 4/20 0.48
PTPN1 P18031 3/20 0.48
ALDH1A1 P00352 2/20 0.48
TLR2 O60603 2/20 0.48
TDP1 Q9NUW8 2/20 0.48
FABP4 P15090 2/20 0.48
KMT2A Q03164 2/20 0.48
SLC22A6 Q4U2R8 1/20 0.48
SLC22A8 Q8TCC7 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Cyclohexane SCHEMBL7426842 0.97 FFAR3 (0.81) FFAR3HDAC3HDAC1HDAC2HDAC8
Cyclohexane SCHEMBL16341925 0.97 FFAR3 (0.81) FFAR3HDAC3HDAC1HDAC2HDAC8
Cyclohexane SCHEMBL3364580 0.97 FFAR3 (0.81) FFAR3HDAC3HDAC1HDAC2HDAC8
Cyclohexane SCHEMBL27815810 0.97 FFAR3 (0.81) FFAR3HDAC3HDAC1HDAC2HDAC8
Butyric Acid SCHEMBL3509473 0.97 FFAR3 (0.81) FFAR3HDAC3HDAC1HDAC2HDAC8
Cyclohexane SCHEMBL458810 0.97 FFAR3 (0.81) FFAR3HDAC3HDAC1HDAC2HDAC8
Butyric Acid SCHEMBL11348636 0.97
Cyclohexane SCHEMBL1316440 0.94 FFAR3 (0.77) FFAR3HDAC3HDAC1HDAC2HDAC8
Cyclohexane SCHEMBL9778100 0.94 FFAR3 (0.77) FFAR3HDAC3HDAC1HDAC2HDAC8
Cyclohexane SCHEMBL3247017 0.94 FFAR3 (0.77) FFAR3HDAC3HDAC1HDAC2HDAC8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2213338-B1 A METHOD OF DETOXIFYING A HARMFUL COMPOUND NIPPON SHEET GLASS CO LTD (JP) 2015-10-14 EP claimed
US-8847000-B2 Composition for alkylation and method for detoxifying a harmful compound by using the composition NIPPON SHEET GLASS COMPANY, LIMITED (JP) 2014-09-30 US claimed
US-8658850-B2 Method of detoxifying a harmful compound NIPPON SHEET GLASS COMPANY, LIMITED (JP) 2014-02-25 US claimed
CN-101583595-B Composition for alkylation and method for detoxifying harmful compound by using the same NIPPON SHEET GLASS CO LTD 2013-07-10 CN claimed
US-20100286424-A1 METHOD OF DETOXIFYING A HARMFUL COMPOUND NIPPON SHEET GLASS COMPANY, LIMITED (JP) 2010-11-11 US claimed
EP-2191871-A1 METHOD FOR DETOXIFYING TOXIC COMPOUND Nippon Sheet Glass Company Limited (JP) 2010-06-02 EP claimed
US-20090326313-A1 Composition for the Alkylation and a Method For Detoxifying a Harmful Compound by Using The Composition NIPPON SHEET GLASS COMPANY, LIMITED (JP) 2009-12-31 US claimed
CN-101583595-A Composition for alkylation and method for detoxifying harmful compound by using the same NIPPON SHEET GLASS CO LTD (JP) 2009-11-18 CN claimed
EP-2055695-A1 COMPOSITION FOR ALKYLATION, AND METHOD FOR DETOXIFICATION OF TOXIC COMPOUND USING THE COMPOSITION Nippon Sheet Glass Company Limited (JP) 2009-05-06 EP claimed
US-5491178-A STABILIZING, INHIBITING THE DEHYDROGENATION BY APPLYING A COATING MIXTURE COMPRISING HINDERED PHENOLS, ORGANIC SULFIDES OR DISULFIDES AND TRANSITION METAL SALTS OR COMPLEXES ALLIEDSIGNAL INC. (US) 1996-02-13 US claimed
EP-2213338-B1 A METHOD OF DETOXIFYING A HARMFUL COMPOUND NIPPON SHEET GLASS CO LTD (JP) 2015-10-14 EP disclosed
US-8847000-B2 Composition for alkylation and method for detoxifying a harmful compound by using the composition NIPPON SHEET GLASS COMPANY, LIMITED (JP) 2014-09-30 US disclosed
US-8658850-B2 Method of detoxifying a harmful compound NIPPON SHEET GLASS COMPANY, LIMITED (JP) 2014-02-25 US disclosed
CN-101583595-B Composition for alkylation and method for detoxifying harmful compound by using the same NIPPON SHEET GLASS CO LTD 2013-07-10 CN disclosed
US-20100305386-A1 METHOD OF DETOXIFYING A HARMFUL COMPOUND NIPPON SHEET GLASS COMPANY, LIMITED (JP) 2010-12-02 US disclosed
EP-2055695-A1 COMPOSITION FOR ALKYLATION, AND METHOD FOR DETOXIFICATION OF TOXIC COMPOUND USING THE COMPOSITION Nippon Sheet Glass Company Limited (JP) 2009-05-06 EP disclosed
US-4628108-A Production of 2-substituted-1,3-dioxolanes from 1,3-dioxolane and formaldehyde TEXACO INC. (US) 1986-12-09 US disclosed
EP-0085815-B1 CATALYSTS USEFUL FOR PREPARING POLYAMIDES THE STANDARD OIL COMPANY (US) 1986-03-26 EP disclosed
US-4459394-A CATALYST, AMMONIUM SALT OF UNSATURATED MONOCARBOXYLIC ACID THE STANDARD OIL COMPANY (US) 1984-07-10 US disclosed
EP-0085815-A1 Catalysts useful for preparing polyamides THE STANDARD OIL COMPANY (US) 1983-08-17 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100286424-A1 METHOD OF DETOXIFYING A HARMFUL COMPOUND SCLY, AS3MT, GSTA2 FFAR3 4728/4885HDAC3 1327/4885HDAC1 1947/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.